文献速递神经PET

11C-甲硫氨酸正电子发射断层显像代谢与体积参数对胶质瘤的预后价值:系统评价与Meta分析

Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis.
PubMed 文献 · AJNR Am J Neuroradiol · 2018-06-28

该系统评价与Meta分析检索181条记录后纳入14项研究,评估11C-甲硫氨酸PET的肿瘤/正常组织比值与代谢性肿瘤体积对胶质瘤生存的预后价值。汇总分析显示,肿瘤/正常组织比值对总生存(HR 2.02)及代谢性肿瘤体积对无事件生存(HR 2.72)和总生存(HR 3.50)均为显著预后因素,但肿瘤/正常组织比值对无事件生存的HR 1.74未达显著。

要点

  • 肿瘤/正常组织比值对总生存的汇总HR为2.02,为显著预后因素。
  • 代谢性肿瘤体积对无事件生存和总生存的汇总HR分别为2.72和3.50,均显著。
  • 肿瘤/正常组织比值对无事件生存的汇总HR为1.74,无显著性。

核心结论

  • 11C-甲硫氨酸PET的肿瘤/正常组织比值对总生存、代谢性肿瘤体积对无事件生存和总生存均为胶质瘤患者的显著预后因素。

研究设计与样本

  • 系统评价与Meta分析,电子检索初检181条记录,最终纳入14项研究,以无事件生存和总生存为结局指标,通过风险比效应量评估预后价值。

诊断标准与关键数值

  • 肿瘤/正常组织比值对无事件生存的汇总HR为1.74,无显著性。
  • 肿瘤/正常组织比值对总生存的汇总HR为2.02,有显著性。
  • 代谢性肿瘤体积对无事件生存的汇总HR为2.72,有显著性。
  • 代谢性肿瘤体积对总生存的汇总HR为3.50,有显著性。

局限性

  • 所选研究均为回顾性研究。
  • 仅4项研究涉及代谢性肿瘤体积。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND: Several studies have demonstrated that 11C-methionine positron-emission tomography provides information on prognosis.

PURPOSE: We performed a systematic review and meta-analysis of the prognostic value of the metabolic and volumetric parameters of 11C-methionine-PET for gliomas.

DATA SOURCES: A systematic search was performed using the following combination of keywords: "methionine," "PET," "glioma," and "prognosis."

STUDY SELECTION: The inclusion criteria were the use of 11C-methionine-PET as an imaging tool, studies limited to gliomas, studies including metabolic parameters (tumor-to-normal ratio) and/or volumetric parameters (metabolic tumor volume), and studies reporting survival data. The electronic search first identified 181 records, and 14 studies were selected.

DATA ANALYSIS: Event-free survival and overall survival were the outcome measures of interest. The effect of the tumor-to-normal ratio and metabolic tumor volume on survival was determined by the effect size of the hazard ratio. Hazard ratios were extracted directly from each study when provided or determined by analyzing the Kaplan-Meier curves.

DATA SYNTHESIS: The combined hazard ratios of the tumor-to-normal ratio for event-free survival was 1.74 with no significance and that of the tumor-to-normal ratio for overall survival was 2.02 with significance. The combined hazard ratio of the metabolic tumor volume for event-free survival was 2.72 with significance and that of the metabolic tumor volume for overall survival was 3.50 with significance.

LIMITATIONS: The studies selected were all retrospective, and there were only 4 studies involving the metabolic tumor volume.

CONCLUSIONS: The present meta-analysis of 11C-methionine-PET suggests that the tumor-to-normal ratio for overall survival and the metabolic tumor volume for event-free survival and overall survival are significant prognostic factors for patients with gliomas.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Kim YI, Kim Y, Lee JY, et al. Prognostic Value of the Metabolic and Volumetric Parameters of 11C-Methionine Positron-Emission Tomography for Gliomas: A Systematic Review and Meta-Analysis. AJNR Am J Neuroradiol. 2018. PMID: 29954817. doi:10.3174/ajnr.A5707

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。